Nd Assessment in Septic Mice Treated with Different Recombinant HDLsTwenty-four hours

Nd Assessment in Septic Mice Treated with Different Recombinant HDLsTwenty-four hours after LPS injection, the lungs were isolated and fixed in 10 formaldehyde solution at room temperature and routinely processed for paraffin embedding. Immunohistochemical staining was carried out on tissue microarray sections according to the manufacturer’s instructions. Positive and negative immunohistochemistry controls were routinely used.Results Different Effect of rHDLs on the Expression of Inflammatory Cytokines in the Plasma of Endotoxemic MiceTo determine the effect of the three rHDLs on endotoxemic mice, we evaluated the plasma levels of CRP, MCP-1 and CD14 by ELISA. As shown in Figure 1A, 24 h after LPS injection, mice receiving rHDLwt exhibited significantly lower levels of plasma CRP (7.3360.89 mg/ml, P,0.001) compared with the LPS group (11.0261.58 mg/ml). Compared to mice treated with rHDLwt, mice treated with rHDL74 also showed a significant decrease in levels of plasma CRP (rHDL74:4.9660.72 mg/ml, P = 0.006 vs. rHDLwt). Interestingly, mice treated with Anlotinib web rHDL228 had much higher plasma levels of CRP (rHDL228:12.8561.35 mg/ml, P = 0.014) compared with the LPS group. The mice treated with rHDLwt and rHDL74 exhibited a significantly decreased level of MCP-1 (rHDLwt: 103.43626.37 pg/ml, P,0.001 vs. LPS; rHDL74:62.2062.88 pg/ml, P,0.001 vs. LPS) compared with the LPS group (309.65633.11 pg/ml) (Fig. 1B). Mice receiving rHDL74 also had decreased plasma levels of MCP-1 (P = 0.013) compared to mice treated with rHDLwt. The level of MCP-1 in mice treated with rHDL74 was close to the saline group (rHDL74:62.2062.88 pg/ml; saline: 57.0060.70 pg/ml, P = 0.73). However, mice treated with rHDL228 had significantly higher levels of MCP-1 compared to those treated with LPS only (rHDL228:453.2269.19 pg/ml, P,0.001 vs. LPS). We also found that mice treated with rHDL74 and rHDLwt had significantly reduced levels of plasma CD14 compared with the LPS group (rHDL74:20.0060.95 ng/ml, P,0.001 vs. LPS; rHDLwt: 21.4561.52 ng/ml, P = 0.001 vs. LPS), but we did not observe any significant differences between rHDL74 and rHDLwt in reducing plasma CD14 (P = 0.702) (Fig. 1C).The Construction of the RAW264.7 Inflammation Model and the Effect of Different Recombinant HDLs on the RAW264.7 Inflammation ModelRAW 264.7 macrophages were Human parathyroid hormone-(1-34) site maintained in DMEM supplemented with 10 (v/v) fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin at 37uC (5 CO2). Exponentially growing RAW264.7 cells were digested with 2.5 mg/ml trypsin and suspended in DMEM to a concentration of 26105 cells/ml, and the total number of cells was determined with a hemocytometer. Subsequently, the cells were plated in 6-well flat-bottomed microculture plates (2 ml/well) and cultured at 37uC in a 5 CO2 atmosphere for 4 h. The cultures were washed to remove nonadherent cells and then incubated with 2 ml of DMEM supplemented with 10 (v/v) fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin for an additional 20 h. The cell plates were randomly divided into three incubation periods after treatment with rHDL: 12 h, 24 h and 48 hs. For each incubation period, there were five groups: control group: served as control without any treatment; LPS group: received only LPS to induce inflammation; and rHDL74, rHDL228 and rHDLwt groups: received LPS and then treated with rHDL74, rHDL228 and rHDLwt, respectively. The culture medium of all groups was replaced with FBS-free DMEM for 30 minutes t.Nd Assessment in Septic Mice Treated with Different Recombinant HDLsTwenty-four hours after LPS injection, the lungs were isolated and fixed in 10 formaldehyde solution at room temperature and routinely processed for paraffin embedding. Immunohistochemical staining was carried out on tissue microarray sections according to the manufacturer’s instructions. Positive and negative immunohistochemistry controls were routinely used.Results Different Effect of rHDLs on the Expression of Inflammatory Cytokines in the Plasma of Endotoxemic MiceTo determine the effect of the three rHDLs on endotoxemic mice, we evaluated the plasma levels of CRP, MCP-1 and CD14 by ELISA. As shown in Figure 1A, 24 h after LPS injection, mice receiving rHDLwt exhibited significantly lower levels of plasma CRP (7.3360.89 mg/ml, P,0.001) compared with the LPS group (11.0261.58 mg/ml). Compared to mice treated with rHDLwt, mice treated with rHDL74 also showed a significant decrease in levels of plasma CRP (rHDL74:4.9660.72 mg/ml, P = 0.006 vs. rHDLwt). Interestingly, mice treated with rHDL228 had much higher plasma levels of CRP (rHDL228:12.8561.35 mg/ml, P = 0.014) compared with the LPS group. The mice treated with rHDLwt and rHDL74 exhibited a significantly decreased level of MCP-1 (rHDLwt: 103.43626.37 pg/ml, P,0.001 vs. LPS; rHDL74:62.2062.88 pg/ml, P,0.001 vs. LPS) compared with the LPS group (309.65633.11 pg/ml) (Fig. 1B). Mice receiving rHDL74 also had decreased plasma levels of MCP-1 (P = 0.013) compared to mice treated with rHDLwt. The level of MCP-1 in mice treated with rHDL74 was close to the saline group (rHDL74:62.2062.88 pg/ml; saline: 57.0060.70 pg/ml, P = 0.73). However, mice treated with rHDL228 had significantly higher levels of MCP-1 compared to those treated with LPS only (rHDL228:453.2269.19 pg/ml, P,0.001 vs. LPS). We also found that mice treated with rHDL74 and rHDLwt had significantly reduced levels of plasma CD14 compared with the LPS group (rHDL74:20.0060.95 ng/ml, P,0.001 vs. LPS; rHDLwt: 21.4561.52 ng/ml, P = 0.001 vs. LPS), but we did not observe any significant differences between rHDL74 and rHDLwt in reducing plasma CD14 (P = 0.702) (Fig. 1C).The Construction of the RAW264.7 Inflammation Model and the Effect of Different Recombinant HDLs on the RAW264.7 Inflammation ModelRAW 264.7 macrophages were maintained in DMEM supplemented with 10 (v/v) fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin at 37uC (5 CO2). Exponentially growing RAW264.7 cells were digested with 2.5 mg/ml trypsin and suspended in DMEM to a concentration of 26105 cells/ml, and the total number of cells was determined with a hemocytometer. Subsequently, the cells were plated in 6-well flat-bottomed microculture plates (2 ml/well) and cultured at 37uC in a 5 CO2 atmosphere for 4 h. The cultures were washed to remove nonadherent cells and then incubated with 2 ml of DMEM supplemented with 10 (v/v) fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin for an additional 20 h. The cell plates were randomly divided into three incubation periods after treatment with rHDL: 12 h, 24 h and 48 hs. For each incubation period, there were five groups: control group: served as control without any treatment; LPS group: received only LPS to induce inflammation; and rHDL74, rHDL228 and rHDLwt groups: received LPS and then treated with rHDL74, rHDL228 and rHDLwt, respectively. The culture medium of all groups was replaced with FBS-free DMEM for 30 minutes t.